Here are 95 oncologists and oncology leaders stepping into new roles in 2024:
The Latest
In an interactive session hosted by GRAIL at Becker's 11th Annual CEO + CFO Roundtable, Roni Christopher, DHSc, senior director of care delivery at GRAIL, and Adam Whitten, vice president of operations at Mercy (St. Louis), discussed how multi-cancer early…
Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.
This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.
Los Angeles-based UCLA Health appointed Mediget Teshome, MD, chief of breast surgery and director of breast health.
The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer.
Drugmakers have their sights set on a class of cancer drugs known as antibody drug conjugates, or ADCs, to drive growth, CNBC reported Jan. 14.
The expected increase in new cancer diagnoses this year is record-setting, even as overall cancer mortality is expected to continue its decline, the American Cancer Society said in its latest report.
Substance use disorders are highly variable among cancer patient populations, and new research points to five cancers with the highest prevalence of SUDs, according to a study published Jan. 11 in JAMA.
A combination of artificial intelligence and image screening software used by a blogger allegedly found evidence of data manipulation across a range of research papers published by four experts at the Dana-Farber Cancer Institute in Boston dating back to 1997.